A Phase II Study to Evaluate NH102 for Depression

Clinical trial NCT06842992 · COMPLETED

Trial details

NCT number: NCT06842992
Sponsor: Jiangsu Nhwa Pharmaceutical Co., Ltd.
Status: COMPLETED
Phase: Phase 2
Study type: INTERVENTIONAL

Major Depressive Disorder (MDD)

Start date: 2024-12-04
Primary completion: 2025-07-30
Enrollment: 243

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.